Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
BIIB076 · 1 trial · 2 indications
Safety surveillance
| Arm | Type | Description |
|---|---|---|
| Cohort HV1 | EXPERIMENTAL | - |
| Cohort HV2 | EXPERIMENTAL | - |
| Cohort HV3 | EXPERIMENTAL | - |
| Cohort HV4 | EXPERIMENTAL | - |
| Cohort HV5 | EXPERIMENTAL | - |
| Cohort AD1 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| BIIB076 | DRUG | Administered as single intravenous (IV) infusion |
| Placebo | DRUG | Administered as single IV infusion |
Key Inclusion Criteria - Healthy Participants * Must be in good health as determined by the Investigator, based on medical history and Screening evaluations. Key Inclusion Criteria - Participants with Alzheimer's Disease (AD) * Must meet all of the clinical criteria for mild cognitive impairment ...
Top 20 of 24 competitors
BIIB076 is an investigational small molecule being developed for Alzheimer's Disease. It is currently in Phase 1 clinical development, meaning it has not been approved by regulatory authorities and is still being studied for safety and tolerability in clinical trials.
BIIB076 is being developed by Biogen Inc., a biotechnology company traded on the NASDAQ under the ticker symbol BIIB. Biogen is conducting clinical research on this investigational therapy for Alzheimer's Disease.
BIIB076 is in Phase 1 clinical development. It is an investigational drug and has not received regulatory approval. The drug is being studied in early-stage clinical trials to evaluate its safety, tolerability, and pharmacokinetics in humans.
BIIB076 has one completed Phase 1 clinical trial, identified as NCT03056729. This was a single-ascending-dose study conducted in the United States, enrolling 46 participants, including healthy volunteers and individuals with Alzheimer's Disease. The trial was randomized, double-blind, and controlled.
BIIB076 is the investigational name for this drug candidate developed by Biogen. No alternative names have been disclosed in the available information. It is a distinct small molecule being studied for Alzheimer's Disease.